she was receiving, in addition to glyceryl trinitrate and isosorbide dinitrate, digoxin 0f25 mg, methyldopa 2f0 g, propranolol 360 mg, frusemide 80 mg, potassium chloride 16 mEq, and chlorpropamide 750 mg every day.
This report describes a patient about to undergo percutaneous transluminal coronary angioplasty in whom focal coronary spasm persisted after sublingual administration of glyceryl trinitrate, thereby simulating a purely organic stenosis. It suggests means for avoiding the danger of an inappropriate intervention.
Case Report
A 52-year-old nurse with unstable angina pectoris was scheduled for coronary angioplasty.
She was found to have essential hypertension in 1967, and adult onset diabetes mellitus in 1978. There was no family history of coronary artery disease and she was a non-smoker. In December 1978 she developed typical effort angina; this was soon followed by an attack of severe pain at rest and she was admitted to a local hospital on she was receiving, in addition to glyceryl trinitrate and isosorbide dinitrate, digoxin 0f25 mg, methyldopa 2f0 g, propranolol 360 mg, frusemide 80 mg, potassium chloride 16 mEq, and chlorpropamide 750 mg every day.
On her admission to the Medical College of Pennsylvania physical examination was normal and her blood pressure was 150/90 mmHg. Her chest x-ray and laboratory tests, including total cholesterol, were normal. The triglycerides were raised at 2-77 mmol/l (245 mg/100 ml) (upper limit of normal 2-03 mmol/l (180 mg/dl). The electrocardiogram showed a biphasic T wave in aVF associated with a mean frontal plane QRS axis of +30 degrees. Glyceryl trinitrate paste 1 cm was added to her regimen at bedtime and led rapidly to the disappearance of anginal attacks.
Cardiac catheterisation was carried out on 30 April 1979. The aortic pressure was 194/102 mmHg and the left ventricular pressure 194/23 (post-'a') mmHg. The left ventriculogram was normal and the ejection fraction 0-80. The dominant right, left main, and circumflex arteries were free of disease. The anterior descending artery had a proximal, localised, concentric, noncalcified 80% stenosis with good vessel quality distal to the obstruction. The stenosis persisted on angiograms repeated after the administration of a total of 0-8 mg sublingual glyceryl trinitrate ( Fig.  1 ) and was deemed amenable to percutaneous trans-581
Lamberto, Bentivoglio, Gruntzig luminal coronary angioplasty. Accordingly she was discharged on the same treatment to be readmitted for a stress test with 201 thallium perfusion scan followed by elective percutaneous transluminal coronary angioplasty. She became exhausted during stage 3 of the Bruce protocol at a heart rate of 103/minute without chest pain or ST segment changes. The 201 thallium scan was equivocal. On the day scheduled for angioplasty a preliminary coronary angiogram confirmed the presence of an 80 per cent stenosis of the anterior descending artery. When, however, angiography was repeated after the intracoronary injection of 40 ug sterile solution of glyceryl trinitrate in normal saline the stenosis was found to have decreased to 50% or less of the lumen diameter, not severe enough to justify dilatation (Fig. 2) . She was discharged on 17 May 1979 on a coronary vasodilator regimen which included isosorbide dinitrate and nifedipine both in initial doses of 10 mg four times a day. At follow-up on 21 September 1979 she remained symptom free.
Discussion
Percutaneous transluminal coronary angioplasty is now employed in several centres. Because the procedure carries some risks every effort should be made to exclude patients who are unsuitable. Unfortunately the geometry of organic coronary artery stenosis which is suitable for dilatation (proximal, isolated, concetric, and uncalcified) is mimicked by coronary spasm, and this must be ruled out before angioplasty is attempted. According to recent experience sublingual glyceryl trinitrate is very effective in relieving coronary spasm24; the persistence of stenosis after administration of the drug by Coronary spasm and intracoronary glyceryl trinitrate this route is taken as solid evidence of its organic nature. It has also been thought to be reliable in eliminating, and thereby unmasking, the spastic component of a subcritical organic obstruction.3 5 There is at least one recorded case, however, in which the failure of sublingual glyceryl trinitrate to relieve coronary spasm is documented,3 and one of us has had a similar experience. It is possible, moreover, that in a patient with left main coronary artery stenosis who died suddenly two months after percutaneous transluminal coronary angioplasty and in whom necropsy disclosed little evidence of atherosclerosis of this vessel,' that spasm was the cause of death. This patient had received sublingual glyceryl trinitrate both before and during the procedure. Because of this danger one of the authors (LGB) now gives up to 100 ,ug intracoronary glyceryl trinitrate when indicated during diagnostic coronary angiography, and also for the relief of ergonovine-induced spasm in patients with histories compatible with variant angina who have normal control arteriograms. There have been no side effects or complications in over 50 cases.
The complete mechanism by which intracoronary glyceryl trinitrate relieves spasm resistant to the drug given sublingually can only be speculated upon. But two advantages are obvious. Firstly, all question of variable absorption is eliminated6 so that the effective dose can be exact. Secondly, this quantity, since it is delivered directly to the coronary artery, can be quite large and locally very potent,* but has little or no systemic and in particular no hypotensive action. The differences may explain in part the observations made in the case being discussed. 
